Johnson & Johnson JNJ
NYSE JNJ
$255.52 +2.24 (+0.88%)
As of: Oct 16, 2026 · 3:59 PM EDT

Johnson & Johnson (JNJ) Net Income (2009 - 2026)

Updated

Johnson & Johnson's Net Income was $5.53 billion in Q2 2026, down 0.1% from $5.54 billion a year earlier but up 5.7% from the prior quarter.

Analysis

Johnson & Johnson (JNJ) Net Income (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Johnson & Johnson's Net Income was $21.04 billion through Jun 28, 2026, down 7.2% year-over-year; for FY2025, it was $26.8 billion, up 90.6% from FY2024.

  • Net Income shows a four-year compound annual growth rate of 16.2% (FY2021 to FY2025).
  • In earlier years, Net Income was $14.07 billion in FY2024 (-60.0%), $35.15 billion in FY2023 (+95.9%), $17.94 billion in FY2022 and $14.71 billion in FY2021.
  • Quarterly Net Income has moved between -$68 million (Q1 2023) and $26.03 billion (Q3 2023) over five years.
  • Compared with a year earlier, Net Income was higher in four of the last eight quarters, with growth averaging 29.9%.
  • The best year-over-year quarter for Net Income over five years was Q1 2025 (growth of 237.9%); the worst was Q3 2024 (a decline of 89.6%).
  • Per Business Quant data, JNJ's Net Income in the three quarters before Q2 2026 was $5.24 billion (Q1 2026), $5.12 billion (Q4 2025) and $5.15 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 5.53 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 3.62 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 2.51 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn -10.50 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn -248.00 Mn
10 Vertex Pharmaceuticals 126.70 Bn 98.70 Bn 2.84 Bn 1.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 5.53 Bn
Mar 29, 2026 5.24 Bn
Dec 28, 2025 5.12 Bn
Sep 28, 2025 5.15 Bn
Jun 29, 2025 5.54 Bn
Mar 30, 2025 11.00 Bn
Dec 29, 2024 3.43 Bn
Sep 29, 2024 2.69 Bn
Jun 30, 2024 4.69 Bn
Mar 31, 2024 3.26 Bn
Dec 31, 2023 4.05 Bn
Oct 1, 2023 26.03 Bn
Jul 2, 2023 5.14 Bn
Apr 2, 2023 -68.00 Mn
Jan 1, 2023 3.52 Bn
Oct 2, 2022 4.46 Bn
Jul 3, 2022 4.81 Bn
Apr 3, 2022 5.15 Bn
Oct 3, 2021 3.67 Bn
Jul 4, 2021 6.28 Bn
API Access

Johnson & Johnson Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income&ticker=JNJ&period=max&api_key=YOUR_API_KEY